Actively Recruiting
Led by Columbia University · Updated on 2025-07-29
418
Participants Needed
1
Research Sites
25 weeks
Total Duration
C
Columbia University
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
Researchers are evaluating two active evidence-based practice coaching (PC) interventions to improve HIV testing and linkage to care in opioid treatment programs (OTPs) among patients receiving substance use disorder treatment. The study aims to compare the effectiveness of these interventions in increasing HIV testing rates, the sustained implementation of testing and timely linkage to care, and the health outcomes and cost-effectiveness of these approaches. This trial involves multiple sites randomly assigned to different intervention groups or a control condition. The study includes three groups: one receives an HIV Testing Practice Coaching intervention focused on implementing on-site HIV testing and linkage to care; another receives an HIV and Hepatitis C Virus (HCV) Testing Practice Coaching intervention that builds on the HIV PC intervention with additional training and support for combined HIV/HCV testing and care; the control group receives informational resources about HIV rapid testing without coaching. The coaching interventions last about 29 weeks (6 months). Sites provide data on HIV and HCV testing and linkage to care across four 6-month time intervals covering periods before, during, and after the intervention. Participants at the site level provide de-identified aggregate data on patient testing and linkage outcomes. Data collection includes quantitative and qualitative assessments at baseline and follow-up intervals up to 18 months post-randomization. The primary outcome focuses on the proportion of patients tested for HIV at 7-12 months post-intervention, controlling for baseline rates. Secondary outcomes include testing rates at 13-18 months. The study monitors the implementation process, health outcomes, healthcare use, and cost-effectiveness throughout the study period.
CONDITIONS
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote at site level)
Duration - Up to 6 months
Participants engage in implementing HIV testing and linkage to care interventions at their opioid treatment programs, supported by practice coaching or informational resources depending on their assigned condition.
Ongoing site activities during the intervention period
Duration - Up to 18 months post-randomization
Participants' sites provide de-identified aggregate data on HIV and HCV testing and linkage to care at multiple time intervals to assess intervention impact.
Data collection at four 6-month intervals
Total: 1 location
1
Columbia University Medical Center
New York, New York, United States, 10032
Actively Recruiting
L
Lauren Gooden, PhD
T
Terri Liguori, M.Ed., Ed.S.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jemima A Frimpong, Carrigan Parish, Daniel J Feaster...
https://pubmed.ncbi.nlm.nih.gov/37461594Jemima A Frimpong, Carrigan L Parish, Daniel J Feaster...
https://pubmed.ncbi.nlm.nih.gov/37749635